Evidence map›Paper›PMID 36408464›Full record

ArticleDisease markers2022

Prognostic Value of Arterial Lactate Metabolic Clearance Rate in Moderate and Severe Acute Pancreatitis.

Jiji Zeng, Jianhua Wan, Wenhua He, Yong Zhu, Hao Zeng, Pi Liu, Min Gong, Fen Liu, Qiang Shao, Liang Xia and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Jiji ZengDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Jianhua WanDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Wenhua HeDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Yong ZhuDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Hao ZengDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Pi LiuDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Min GongDepartment of Digestive Internal Medicine, Southern Medical University Pingxiang Hospital, Pingxiang, China.
Fen LiuDepartment of Intensive Care Unit, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Qiang ShaoDepartment of Intensive Care Unit, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Liang XiaDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.ORCID https://orcid.org/0000-0001-7209-9407
Yin ZhuDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Youxiang ChenDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Nonghua LuDepartment of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.ORCID https://orcid.org/0000-0003-4373-551X
Nanchang University · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: High lactate levels at hospital admission are significantly associated with poor prognosis in acute pancreatitis patients. Early high lactate clearance is a vital marker for predicting persistent organ failure and mortality in critical illness; however, its value in acute pancreatitis remains unclear. Method: Data were collected from patients who were diagnosed with moderately severe acute pancreatitis and severe acute pancreatitis from January 2017 to December 2020. Initial lactate (within 2 hours after admission) and repeat lactate at 24 hours after admission were measured to determine lactate clearance. Low clearance was defined as a reduction in repeat lactate of less than 30% compared to the first measurement. High clearance was defined as a repeat lactate decrease ≥30% of the first measurement or both first and second lactate levels <2 mmol/L. Baseline data, laboratory data, mortality rate, persistent organ failure rate, and other outcomes such as the incidence of septic pancreatic necrosis and sepsis and the length of hospital stay and intensive care unit (ICU) stay were compared in the low and high lactate clearance groups. Multivariate logistic regression analyses were used to assess the value of lactate clearance for predicting death. Result: Among 4425 acute pancreatitis patients, 3040 patients were diagnosed with moderate or severe acute pancreatitis, and 1028 patients had initial lactate measured. Finally, 390 patients who had initial and 24-hour repeat lactate data were included in the study. Patients who had elevated initial lactate had poor outcomes, and 51 patients in the initial elevated lactate group died. In the lactate normalization group analysis, 293 patients had 24-hour lactate normalization; compared with patients in the nonnormalization group, they had a lower rate of mortality (12.6% vs. 33%). In the lactate clearance group analysis, 70 (21.9%) patients had a low clearance after 24 hours; compared with patients in the high clearance group, they had a higher rate of developing persistent multiorgan failure ( Conclusion: The 24-hour clearance of lactate is a reliable marker to predict the outcome of moderate and severe acute pancreatitis, and low lactate clearance may indicate that the patient's condition will worsen, requiring aggressive treatments to improve patient outcomes.

Indexed as

Lactic AcidPancreatitisAcute DiseaseBiomarkersHumansMetabolic Clearance RatePrognosisBiomarkersLactic Acid

Identifiers

PMID36408464
PMCPMC9668450
OpenAlexW4308731057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.